Abstract:Medline (MDLN.O) jumps 41% on its Nasdaq debut, sparking strong investor interest. Trade Medline shares easily with FXPro as the stock gains global attention.

Medline (MDLN.O) made a remarkable debut on the Nasdaq, soaring 41% on its first day of trading and setting the pace for what is being hailed as 2025s most successful IPO so far. The companys public market entry underscored strong investor demand for healthcare and industrial leaders, even as broader markets remain uncertain.
The IPO attracted significant attention from institutional and retail investors, driving early gains and solidifying Medlines position as a major player to watch in the year ahead. Analysts note that this performance signals renewed confidence in companies rooted in tangible fundamentals, rather than purely tech-driven valuations.
Founded over five decades ago, Medline is among the worlds leading suppliers of medical and surgical products. Its extensive catalog spans everything from everyday consumables to advanced healthcare equipment, supporting hospitals and clinics worldwide.

In an era dominated by tech IPOs, Medlines strong market reception reaffirms the enduring appeal of resilient, essential industries. Its robust business foundation and consistent demand from the healthcare sector provide a stable outlook for investors seeking long-term value.
FXPro now offers traders access to Medline shares, allowing participation in post-IPO movements as the stock finds equilibrium. Through FXPro, investors can:
FXPro continues to expand its share offerings, adding new listings and major IPOs as they go public. Medlines promising start makes it a compelling addition for traders looking to capitalize on the 2025 IPO wave.
CFDs and Spread Betting are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading these products. Please ensure you understand the risks before trading.
FXPro is a leading global broker known for its advanced trading platforms, competitive spreads, and access to a wide range of markets, including stocks, commodities, and major IPOs.


Switched to Galileo FX from other brokers, thinking that you would earn profits, but things went the other way round? Did you continue to face losses despite executing constant optimizations on the trading software? Like did you experience issues concerning executing stop-loss orders? Failed to cash in on the positive market wave because of the broker’s trading bot? You are not alone! Many complaints concerning losses due to trading bot deficiencies have been doing the rounds. In this Galileo FX review article, we have demonstrated these complaints. Take a look!

EGM Securities has been reported as a scam by many forex traders, as they encountered several problems concerning fund withdrawals. The broker is alleged to have defrauded traders by applying unnecessary restrictions on withdrawals. Also known as FXPesa, the broker seems to have caught traders’ attention, mostly for negative reasons, though. In this EGM Securities review article, we have discussed withdrawal-related complaints made against the broker online. Keep reading!

Vebson is listed as high risk on WikiFX, with exposure to unpaid withdrawal cases and misleading claims. Read this forex scam alert before you deposit a cent.

Exposed: Amaraa Capital is a forex scam. Protect your funds—read this detailed scam alert now and avoid risky forex investments.